Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial
伊沙妥昔单抗、卡非佐米、来那度胺和地塞米松诱导治疗新诊断的多发性骨髓瘤:MIDAS试验分析
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024026230
Perrot, Aurore; Touzeau, Cyrille; Lambert, Jerome; Hulin, Cyrille; Caillot, Denis; Karlin, Lionel; Arnulf, Bertrand; Rey, Philippe; Garderet, Laurent; Macro, Margaret; Escoffre Barbe, Martine; Gay, Julie; Chalopin, Thomas; Gounot, Romain; Schiano, Jean-Marc; Tiab, Mourad; Mohty, Mohamad; Kuhnowski, Frederique; Fontan, Jean; Manier, Salomon; Orsini-Piocelle, Frederique; Vincent, Laure; Rigaudeau, Sophie; Leleu, Xavier; Hebraud, Benjamin; Flet, Laurent; Malfuson, Jean-Valere; Jacquet, Caroline; Chaoui, Driss; Meuleman, Nathalie; Abarah, Wajed; Montes, Lydia; Benramdane, Riad; Sonntag, Cecile; Zerazhi, Hacene; Danu, Alina; Allangba, Olivier; Dib, Mamoun; Roussel, Murielle; Cereja, Sophie; Depaus, Julien; Branche, Nicolas; Demarquette, Helene; Richez, Valentine; Cherel, Brieuc; Frenzel, Laurent; Vekemans, Marie-Christiane; Bigot, Noemie; Avet-Loiseau, Herve; Corre, Jill; Moreau, Philippe